Effect of Statin Adherence on Cerebrovascular Disease in Primary Prevention Sylvie Perreault, BPharm, PhD, Laura Ellia, MSc, Alice Dragomir, MSc, Robert Côté, MD, FRCPC, Lucie Blais, PhD, Anick Bérard, PhD, Lyne Lalonde, BPharm, PhD The American Journal of Medicine Volume 122, Issue 7, Pages 647-655 (July 2009) DOI: 10.1016/j.amjmed.2009.01.032 Copyright © 2009 Elsevier Inc. Terms and Conditions
Figure Flow chart of inclusion and exclusion criteria. *Exclusion criteria were assessed in the 2 years preceding cohort entry for medications and in the 5 years preceding cohort entry for hospitalizations, diagnoses, or medical procedures. The American Journal of Medicine 2009 122, 647-655DOI: (10.1016/j.amjmed.2009.01.032) Copyright © 2009 Elsevier Inc. Terms and Conditions